Press "Enter" to skip to content

New patent expiration for Novo Nordisk drug NOVOLOG FLEXTOUCH


Annual Drug Patent Expirations for NOVOLOG+FLEXTOUCH
Annual Drug Patent Expirations for NOVOLOG+FLEXTOUCH

Novolog Flextouch is a drug marketed by Novo Nordisk Inc
and is included in one NDA. It is available from three suppliers. There are eleven patents protecting this drug.

This drug has eigthy-six patent family members in seventeen countries.

The generic ingredient in NOVOLOG FLEXTOUCH is insulin aspart recombinant. Three suppliers are listed for this compound. Additional details are available on the insulin aspart recombinant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

Do NOT follow this link or you will be banned from the site!